Annual Total Liabilities
$124.00 M
+$15.86 M+14.67%
31 December 2023
Summary:
Centessa Pharmaceuticals annual total liabilities is currently $124.00 million, with the most recent change of +$15.86 million (+14.67%) on 31 December 2023. During the last 3 years, it has risen by +$89.86 million (+263.22%). CNTA annual total liabilities is now -64.64% below its all-time high of $350.66 million, reached on 01 June 2019.CNTA Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Liabilities
$110.58 M
-$1.30 M-1.16%
30 September 2024
Summary:
Centessa Pharmaceuticals quarterly total liabilities is currently $110.58 million, with the most recent change of -$1.30 million (-1.16%) on 30 September 2024. Over the past year, it has dropped by -$7.40 million (-6.27%). CNTA quarterly total liabilities is now -19.92% below its all-time high of $138.08 million, reached on 31 December 2021.CNTA Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CNTA Total Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +14.7% | -6.3% |
| 3 y3 years | +263.2% | +75.3% |
| 5 y5 years | -64.6% | - |
CNTA Total Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -10.2% | +263.2% | -19.9% | +75.3% |
| 5 y | 5 years | -64.6% | +263.2% | -19.9% | +164.0% |
| alltime | all time | -64.6% | >+9999.0% | -19.9% | +164.0% |
Centessa Pharmaceuticals Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $110.58 M(-1.2%) |
| June 2024 | - | $111.88 M(-1.0%) |
| Mar 2024 | - | $113.01 M(-8.9%) |
| Dec 2023 | $124.00 M(+14.7%) | $124.00 M(+5.1%) |
| Sept 2023 | - | $117.97 M(+1.4%) |
| June 2023 | - | $116.31 M(+5.2%) |
| Mar 2023 | - | $110.60 M(+2.3%) |
| Dec 2022 | $108.14 M(-21.7%) | $108.14 M(+1.6%) |
| Sept 2022 | - | $106.43 M(+5.4%) |
| June 2022 | - | $101.01 M(-1.0%) |
| Mar 2022 | - | $102.04 M(-26.1%) |
| Dec 2021 | $138.08 M | $138.08 M(+118.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2021 | - | $63.07 M(+8.5%) |
| June 2021 | - | $58.12 M(+38.7%) |
| Mar 2021 | - | $41.89 M |
| Dec 2020 | $34.14 M(-90.0%) | - |
| June 2020 | $341.32 M(-2.7%) | - |
| June 2019 | $350.66 M(+6.2%) | - |
| June 2018 | $330.13 M(+4.1%) | - |
| June 2017 | $317.00 M(+0.7%) | - |
| June 2016 | $314.90 M(+53.9%) | - |
| June 2015 | $204.56 M(>+9900.0%) | - |
| May 2015 | $51.70 K(-12.2%) | - |
| May 2014 | $58.90 K | - |
FAQ
- What is Centessa Pharmaceuticals annual total liabilities?
- What is the all time high annual total liabilities for Centessa Pharmaceuticals?
- What is Centessa Pharmaceuticals annual total liabilities year-on-year change?
- What is Centessa Pharmaceuticals quarterly total liabilities?
- What is the all time high quarterly total liabilities for Centessa Pharmaceuticals?
- What is Centessa Pharmaceuticals quarterly total liabilities year-on-year change?
What is Centessa Pharmaceuticals annual total liabilities?
The current annual total liabilities of CNTA is $124.00 M
What is the all time high annual total liabilities for Centessa Pharmaceuticals?
Centessa Pharmaceuticals all-time high annual total liabilities is $350.66 M
What is Centessa Pharmaceuticals annual total liabilities year-on-year change?
Over the past year, CNTA annual total liabilities has changed by +$15.86 M (+14.67%)
What is Centessa Pharmaceuticals quarterly total liabilities?
The current quarterly total liabilities of CNTA is $110.58 M
What is the all time high quarterly total liabilities for Centessa Pharmaceuticals?
Centessa Pharmaceuticals all-time high quarterly total liabilities is $138.08 M
What is Centessa Pharmaceuticals quarterly total liabilities year-on-year change?
Over the past year, CNTA quarterly total liabilities has changed by -$7.40 M (-6.27%)